All In MedTech

Device Trial Radar · NCT04682483

Cardiogenic Shock Working Group Registry

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20,000

Planned (sponsor's estimate)

Start

Dec 4, 2017

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Tufts Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Abbott; Boston Scientific Corporation; Abiomed Inc.; Getinge Group
First posted
Dec 23, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.

Conditions

  • Cardiogenic Shock

Interventions

  • VasopressorDrug

    The vasopressors include phenylephrine, norepinephrine, epinephrine, dopamine and vasopressin.

  • InotropeDrug

    Inotropes include dobutamine and milrinone.

  • Acute Mechanical Circulatory Support DevicesDevice

    Acute Mechanical Circulatory Support devices include ECMO (VV), ECMO (VA), Impella CP, Impella 2.5, Impella 5.0, Impella 5.5, Impella RP, IABP, Centrimag, Tandem Heart and ProTek Duo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of MortalityTime frame: 30 days after discharge
  2. Rate of MortalityTime frame: 1 year after discharge

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Cleveland Clinic Florida

    Weston, Florida · Completed

  • Northwestern Medicine

    Chicago, Illinois · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.